Back to Search Start Over

Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.

Authors :
Krumpl, Günther
Ulč, Ivan
Trebs, Michaela
Kadlecová, Pavla
Hodisch, Juri
Husch, Bernhard
Source :
Clinical Pharmacology in Drug Development. Mar2022, Vol. 11 Issue 3, p309-317. 9p.
Publication Year :
2022

Abstract

We investigated the hemodynamic effects of 2 short‐acting β1‐blockers, landiolol and esmolol, in the continuous presence of dobutamine in a prospective, single‐center, randomized, crossover study in 16 healthy White volunteers. Dobutamine was infused at a rate sufficient to increase the heart rate by at least 30 beats per minute, followed by a 60‐minute infusion of 50 μg/kg/min esmolol or 10 μg/kg/min landiolol on top of the unchanged dobutamine infusion. Concentrations of β‐blockers and their metabolites in blood, heart rate, and blood pressure were followed for 180 minutes. Landiolol reduced the dobutamine‐induced heart rate and blood pressure increases better than esmolol. After discontinuation of β‐blocker administration, heart rate recovered swiftly to preinfusion values in both study arms. Systolic and diastolic blood pressure recovered partially after landiolol but showed a continued reduction after esmolol. No serious adverse events were observed. The heart rate effect is characteristic for β‐blockers, whereas the blood pressure effects are likely due to direct and indirect β‐blocker effects as well as influences on various ion channels. This may explain why landiolol that is devoid of effects on renin and sodium, calcium, and potassium channels behaves different from esmolol with respect to blood pressure recovery. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
2160763X
Volume :
11
Issue :
3
Database :
Academic Search Index
Journal :
Clinical Pharmacology in Drug Development
Publication Type :
Academic Journal
Accession number :
155486365
Full Text :
https://doi.org/10.1002/cpdd.1025